RLN1
Basic information
Region (hg38): 9:5334930-5339876
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RLN1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 15 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 3 | 1 |
Variants in RLN1
This is a list of pathogenic ClinVar variants found in the RLN1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-5335283-A-G | not specified | Uncertain significance (Feb 16, 2023) | ||
9-5335342-T-G | not specified | Uncertain significance (Apr 22, 2022) | ||
9-5335346-T-C | not specified | Uncertain significance (Feb 28, 2024) | ||
9-5335393-T-C | not specified | Uncertain significance (Jan 30, 2024) | ||
9-5335408-C-T | not specified | Likely benign (May 09, 2023) | ||
9-5335439-G-C | not specified | Uncertain significance (May 02, 2024) | ||
9-5335519-T-G | not specified | Uncertain significance (May 20, 2024) | ||
9-5335554-A-C | not specified | Uncertain significance (Apr 14, 2022) | ||
9-5335570-T-C | not specified | Uncertain significance (May 13, 2024) | ||
9-5335590-T-G | Benign (Feb 13, 2018) | |||
9-5339550-G-A | not specified | Uncertain significance (Feb 27, 2023) | ||
9-5339580-G-C | not specified | Uncertain significance (Sep 14, 2022) | ||
9-5339601-A-G | not specified | Uncertain significance (Apr 06, 2024) | ||
9-5339635-C-G | not specified | Uncertain significance (Feb 16, 2023) | ||
9-5339656-C-T | not specified | Uncertain significance (Dec 12, 2023) | ||
9-5339664-T-A | not specified | Likely benign (Aug 18, 2021) | ||
9-5339670-T-G | not specified | Uncertain significance (Aug 18, 2021) | ||
9-5339673-G-T | not specified | Uncertain significance (Aug 18, 2021) | ||
9-5339688-G-A | not specified | Uncertain significance (Dec 07, 2021) | ||
9-5339689-A-G | not specified | Likely benign (Jan 03, 2024) | ||
9-5339695-G-C | not specified | Uncertain significance (May 30, 2024) | ||
9-5339712-A-G | not specified | Uncertain significance (Feb 28, 2024) | ||
9-5339739-C-A | not specified | Uncertain significance (Dec 03, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RLN1 | protein_coding | protein_coding | ENST00000223862 | 2 | 4905 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00652 | 0.530 | 107205 | 0 | 4 | 107209 | 0.0000187 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.64 | 146 | 99.9 | 1.46 | 0.00000498 | 1201 |
Missense in Polyphen | 39 | 28.229 | 1.3816 | 361 | ||
Synonymous | -0.844 | 47 | 40.2 | 1.17 | 0.00000208 | 356 |
Loss of Function | 0.0104 | 3 | 3.02 | 0.994 | 1.29e-7 | 34 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000870 | 0.0000859 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000324 | 0.0000321 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Relaxin is an ovarian hormone that acts with estrogen to produce dilatation of the birth canal in many mammals. May be involved in remodeling of connective tissues during pregnancy, promoting growth of pubic ligaments and ripening of the cervix.;
- Pathway
- Relaxin signaling pathway - Homo sapiens (human);Androgen receptor signaling pathway;Myometrial Relaxation and Contraction Pathways;Cellular response to heat stress;Signaling by GPCR;Signal Transduction;HSF1 activation;Attenuation phase;HSF1-dependent transactivation;Regulation of HSF1-mediated heat shock response;Cellular responses to stress;G alpha (s) signalling events;Relaxin receptors;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;Cellular responses to external stimuli;Cellular response to heat stress;GPCR downstream signalling
(Consensus)
Intolerance Scores
- loftool
- 0.541
- rvis_EVS
- -0.09
- rvis_percentile_EVS
- 46.74
Haploinsufficiency Scores
- pHI
- 0.164
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.412
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.129
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rln1
- Phenotype
- endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype;
Gene ontology
- Biological process
- signal transduction;female pregnancy;regulation of signaling receptor activity
- Cellular component
- extracellular region
- Molecular function
- hormone activity